On March 19, 2024, Cytiva and White Raven, a Belgium-based contract development and manufacturing organization (CDMO), announced that White Raven has selected Cytiva’s SA25 Aseptic Filling Workcell for its fill/finish site. The installation of the workcell will complete White Raven’s drug product platform and increase its manufacturing efficiency. White Raven’s site is expected to be good manufacturing practice (GMP)-compliant by the end of 2024.
